Oxcarbazepine Tablet, Film Coated
Product Images NDC 71335-2548

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 71335-2548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352548)

Label for Oxcarbazepine Tablets USP 300 mg, film-coated, packaged in a bottle of 30 tablets. The label includes the NDC 71335-2548-1 and states it is Rx only. Repackaged by Bryant Ranch Prepack and manufactured by Annora Pharma Pvt. Ltd. The label contains storage instructions, a barcode, and QR codes for additional product information and package insert.*

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

Kaplan-Meier curve displaying exit rate versus time on trial (days) starting from Day 2 at 8 am. The graph compares treatment groups for Oxcarbazepine (solid line) and placebo (dotted line), with a log-rank test p-value of 0.0001 shown on the plot.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

A line graph depicting seizure rate over time (days) from the first dose to first seizure for two treatment groups: Oxcarbazepine and Placebo. The x-axis shows days from 0 to 140, and the y-axis shows seizure rate from 0.0 to 1.0. The graph includes a log-rank test with a p-value of 0.046 comparing the two groups.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

A Kaplan-Meier survival curve graph illustrating exit rates over time in days for two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days (0 to 130), and the y-axis shows the exit rate from 0.0 to 1.0. The HIGH group is shown with a solid line, and the LOW group with a dashed line. A log-rank test p-value of 0.0001 is displayed, indicating statistical analysis of the difference between the two groups.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

A Kaplan-Meier survival curve plotting exit rate over time (days) for two treatment groups labeled LOW and HIGH. The LOW group is represented by a dotted line, while the HIGH group uses a solid line. The graph includes a log-rank test p-value of 0.0001.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

Chemical structure of oxcarbazepine, depicting the molecular framework including two fused aromatic rings and a central seven-membered ring containing a nitrogen atom and amide group.*

FDA Label Image

Oxcarbazipinetabcamberlogo1 (Oxcarbazipinetabcamberlogo1)

FDA Label Image

Oxcarbazipinetabcamberlogo2 (Oxcarbazipinetabcamberlogo2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.